- Home
- PULM vs ELBM Comparison
PULM vs ELBM Comparison
Compare PULM & ELBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- ELBM
- Stock Information
- Founded
- PULM 2003
- ELBM 2011
- Country
- PULM United States
- ELBM Canada
- Employees
- PULM N/A
- ELBM N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- ELBM Industrial Machinery/Components
- Sector
- PULM Health Care
- ELBM Miscellaneous
- Exchange
- PULM Nasdaq
- ELBM Nasdaq
- Market Cap
- PULM 18.3M
- ELBM 19.2M
- IPO Year
- PULM N/A
- ELBM N/A
- Fundamental
- Price
- PULM $4.87
- ELBM $1.40
- Analyst Decision
- PULM
- ELBM Strong Buy
- Analyst Count
- PULM 0
- ELBM 2
- Target Price
- PULM N/A
- ELBM $2.20
- AVG Volume (30 Days)
- PULM 17.6K
- ELBM 21.9M
- Earning Date
- PULM 10-16-2025
- ELBM 11-14-2025
- Dividend Yield
- PULM N/A
- ELBM N/A
- EPS Growth
- PULM N/A
- ELBM N/A
- EPS
- PULM N/A
- ELBM N/A
- Revenue
- PULM $3,000.00
- ELBM N/A
- Revenue This Year
- PULM N/A
- ELBM N/A
- Revenue Next Year
- PULM $134.88
- ELBM N/A
- P/E Ratio
- PULM N/A
- ELBM N/A
- Revenue Growth
- PULM N/A
- ELBM N/A
- 52 Week Low
- PULM $2.00
- ELBM $0.77
- 52 Week High
- PULM $10.40
- ELBM $8.70
- Technical
- Relative Strength Index (RSI)
- PULM 50.82
- ELBM 46.88
- Support Level
- PULM $4.55
- ELBM $1.31
- Resistance Level
- PULM $4.95
- ELBM $1.91
- Average True Range (ATR)
- PULM 0.21
- ELBM 1.01
- MACD
- PULM 0.02
- ELBM -0.18
- Stochastic Oscillator
- PULM 46.72
- ELBM 1.15
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About ELBM Electra Battery Materials Corporation
Electra Battery Materials Corp is building North America's fully integrated, localized, and environmentally sustainable battery materials park. Electra Battery Materials is an integral part of the North American battery supply chain, providing low-carbon, sustainable, and traceable raw materials for the region's fast growing electric vehicle industry.